KYLE CASEY: Open Payments
NPI 1356844518 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 20 payments from 14 companies in 2025. Trend: 2023 $345 · 2024 $561 · 2025 $606
Food & beverage: $486Education: $120
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $185 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Aveo Pharmaceuticals, Inc. | 2 | $58 |
| Exelixis Inc. | 1 | $44 |
| Eisai Inc. | 2 | $37 |
| Blueprint Medicines Corporation | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $27 |
| EMD Serono, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $26 |
Products named: DARZALEX, RYBREVANT, SCEMBLIX, FOTIVDA, CABOMETYX, Lenvima, AYVAKIT, Enhertu.
Industry payments across TN — which companies pay providers there.
